Syndax Pharmaceuticals, Inc. (NasdaqGS: SNDX)
Health Care · Biotechnology · US
$16.90
-3.98% today · +7.3% 1Y
Syndax Pharmaceuticals, Inc. (NasdaqGS: SNDX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.57B and employs 298 people.
Over the last twelve months the share price has gained 7.3%, trading between 12.99 and 25.59.
Tweenvest scores Syndax Pharmaceuticals, Inc. across four factors: quality 33/100, value 71/100. Its strongest factor is value.
SNDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.57B
- Revenue (TTM)
- $252.25M
- P/E
- —
- EPS
- -2.51
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- $25.59
- 52-week low
- $12.99
- Avg volume (3M)
- —
- Shares outstanding
- 89.30M
- Employees
- 298
- Next earnings
- —
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm focused on developing innovative therapies for cancer. Among its leading investigational products are SNDX-5613, currently undergoing Phase 1/2 clinical assessment, which targets the Menin-mixed lineage leukemia 1 protein interaction for treating MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML). Another significant candidate is SNDX-6352, or axatilimab, a monoclonal antibody designed to block the colony stimulating factor 1 (CSF-1) receptor, intended for patients suffering from chronic graft versus host disease (cGVHD). The company is additionally progressing Entinostat. Syndax has also established strategic collaborations, including a research and development agreement with the National Cancer Institute, a clinical trial agreement with the Eastern Cooperative Oncology Group, and a license agreement with Kyowa Hakko Kirin Co., Ltd. Founded in 2005, Syndax Pharmaceuticals, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
- ISIN
- US87164F1057
- Founded
- 2005
- Listed since
- Mar 2, 2016
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Novoprotein Scientific Inc.SHSE: 688137 | $1.66B | CN¥160.39 | +28.06% |
| InventisBio Co., LimitedSHSE: 688382 | $1.65B | CN¥19.07 | +1.71% |
| COMPASS Pathways plcNasdaqGS: CMPS | $1.59B | $11.47 | -1.88% |
| Yantai Dongcheng Pharmaceutical Group Co.,Ltd.SZSE: 002675 | $1.59B | CN¥12.90 | +1.74% |
| uniQure N.V.NasdaqGS: QURE | $1.56B | $22.54 | -2.59% |
| Wedge Industrial Co.,Ltd.SZSE: 000534 | $1.56B | CN¥21.63 | -4.46% |
| Stoke Therapeutics, Inc.NasdaqGS: STOK | $1.55B | $23.95 | -1.40% |
| Absci CorporationNasdaqGS: ABSI | $1.53B | $8.94 | -3.04% |
Figures last refreshed Oct 4, 2026.